CompletedNot Applicable

Platelet Rich Plasma and Supraspinatus Tear

Egypt40 participantsStarted 2019-06-01

Plain-language summary

Rheumatology and Rehabilitation Department, Mansoura University Hospital. Forty patients with chronic partial supraspinatus tears will be included in the study. The diagnosis of the supraspinatus tear will be made by ultrasound examination

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: chronic partial supraspinatus tears will be included in the study Exclusion Criteria: age \> 80 years, pregnancy, full thickness supraspinatus tears, other rotator cuff lesions with/without supraspinatus tears, systemic disorders such as diabetes rheumatoid arthritis, hematological diseases (co-agulopathy),

What they're measuring

change of pain from base line

Timeframe: immediately before injection,6 weeks after injection,12 weeks after injection

change of range of motion from base line

Timeframe: immediately before injection,6 weeks after injection,12 weeks after injection

Trial details

NCT IDNCT03942679

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-01

View on ClinicalTrials.gov More Supraspinatus Tear trials